ID HGFA_HUMAN Reviewed; 655 AA. AC Q04756; Q14726; Q2M1W7; Q53X47; DT 01-JUN-1994, integrated into UniProtKB/Swiss-Prot. DT 01-JUN-1994, sequence version 1. DT 24-JAN-2024, entry version 207. DE RecName: Full=Hepatocyte growth factor activator; DE Short=HGF activator; DE Short=HGFA; DE EC=3.4.21.-; DE Contains: DE RecName: Full=Hepatocyte growth factor activator short chain; DE Contains: DE RecName: Full=Hepatocyte growth factor activator long chain; DE Flags: Precursor; GN Name=HGFAC; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; OC Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA], AND PARTIAL PROTEIN SEQUENCE. RC TISSUE=Liver, and Serum; RX PubMed=7683665; DOI=10.1016/s0021-9258(18)82167-6; RA Miyazawa K., Shimomura T., Kitamura A., Kondo J., Morimoto Y., Kitamura N.; RT "Molecular cloning and sequence analysis of the cDNA for a human serine RT protease responsible for activation of hepatocyte growth factor. Structural RT similarity of the protease precursor to blood coagulation factor XII."; RL J. Biol. Chem. 268:10024-10028(1993). RN [2] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA]. RX PubMed=9874200; DOI=10.1046/j.1432-1327.1998.2580355.x; RA Miyazawa K., Wang Y., Minoshima S., Shimizu N., Kitamura N.; RT "Structural organization and chromosomal localization of the human RT hepatocyte growth factor activator gene -- phylogenetic and functional RT relationship with blood coagulation factor XII, urokinase, and tissue-type RT plasminogen activator."; RL Eur. J. Biochem. 258:355-361(1998). RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RX PubMed=15815621; DOI=10.1038/nature03466; RA Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H., Minx P., RA Wagner-McPherson C., Layman D., Wylie K., Sekhon M., Becker M.C., RA Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Kremitzki C., Oddy L., RA Du H., Sun H., Bradshaw-Cordum H., Ali J., Carter J., Cordes M., Harris A., RA Isak A., van Brunt A., Nguyen C., Du F., Courtney L., Kalicki J., RA Ozersky P., Abbott S., Armstrong J., Belter E.A., Caruso L., Cedroni M., RA Cotton M., Davidson T., Desai A., Elliott G., Erb T., Fronick C., Gaige T., RA Haakenson W., Haglund K., Holmes A., Harkins R., Kim K., Kruchowski S.S., RA Strong C.M., Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K., RA McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C., RA Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N., Swearengen-Shahid S., RA Snider J., Strong J.T., Thompson J., Yoakum M., Leonard S., Pearman C., RA Trani L., Radionenko M., Waligorski J.E., Wang C., Rock S.M., RA Tin-Wollam A.-M., Maupin R., Latreille P., Wendl M.C., Yang S.-P., Pohl C., RA Wallis J.W., Spieth J., Bieri T.A., Berkowicz N., Nelson J.O., Osborne J., RA Ding L., Meyer R., Sabo A., Shotland Y., Sinha P., Wohldmann P.E., RA Cook L.L., Hickenbotham M.T., Eldred J., Williams D., Jones T.A., She X., RA Ciccarelli F.D., Izaurralde E., Taylor J., Schmutz J., Myers R.M., RA Cox D.R., Huang X., McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C., RA Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S., RA Miller W., Eichler E.E., Bork P., Suyama M., Torrents D., Waterston R.H., RA Wilson R.K.; RT "Generation and annotation of the DNA sequences of human chromosomes 2 and RT 4."; RL Nature 434:724-731(2005). RN [4] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RA Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M., RA Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., RA Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., RA Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H., RA Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K., RA Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D., RA Hunkapiller M.W., Myers E.W., Venter J.C.; RL Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases. RN [5] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT LEU-231. RC TISSUE=Liver; RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA project: RT the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [6] RP PROTEIN SEQUENCE OF 36-50. RX PubMed=15340161; DOI=10.1110/ps.04682504; RA Zhang Z., Henzel W.J.; RT "Signal peptide prediction based on analysis of experimentally verified RT cleavage sites."; RL Protein Sci. 13:2819-2824(2004). RN [7] RP GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-468. RC TISSUE=Plasma; RX PubMed=16335952; DOI=10.1021/pr0502065; RA Liu T., Qian W.-J., Gritsenko M.A., Camp D.G. II, Monroe M.E., Moore R.J., RA Smith R.D.; RT "Human plasma N-glycoproteome analysis by immunoaffinity subtraction, RT hydrazide chemistry, and mass spectrometry."; RL J. Proteome Res. 4:2070-2080(2005). RN [8] RP GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-468. RC TISSUE=Liver; RX PubMed=19159218; DOI=10.1021/pr8008012; RA Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.; RT "Glycoproteomics analysis of human liver tissue by combination of multiple RT enzyme digestion and hydrazide chemistry."; RL J. Proteome Res. 8:651-661(2009). RN [9] RP X-RAY CRYSTALLOGRAPHY (2.6 ANGSTROMS) OF 373-655 ALONE AND IN COMPLEX WITH RP INHIBITOR HAI1B, ACTIVE SITE, AND DISULFIDE BONDS. RX PubMed=15713485; DOI=10.1016/j.jmb.2004.12.048; RA Shia S., Stamos J., Kirchhofer D., Fan B., Wu J., Corpuz R.T., Santell L., RA Lazarus R.A., Eigenbrot C.; RT "Conformational lability in serine protease active sites: structures of RT hepatocyte growth factor activator (HGFA) alone and with the inhibitory RT domain from HGFA inhibitor-1B."; RL J. Mol. Biol. 346:1335-1349(2005). RN [10] RP X-RAY CRYSTALLOGRAPHY (2.2 ANGSTROMS) OF 373-655 IN COMPLEX WITH ANTIBODY, RP GLYCOSYLATION AT ASN-468, AND DISULFIDE BONDS. RX PubMed=18077410; DOI=10.1073/pnas.0708251104; RA Wu Y., Eigenbrot C., Liang W.C., Stawicki S., Shia S., Fan B., Ganesan R., RA Lipari M.T., Kirchhofer D.; RT "Structural insight into distinct mechanisms of protease inhibition by RT antibodies."; RL Proc. Natl. Acad. Sci. U.S.A. 104:19784-19789(2007). CC -!- FUNCTION: Activates hepatocyte growth factor (HGF) by converting it CC from a single chain to a heterodimeric form. CC -!- SUBUNIT: Heterodimer of a short chain and a long chain linked by a CC disulfide bond. {ECO:0000269|PubMed:15713485, CC ECO:0000269|PubMed:18077410}. CC -!- INTERACTION: CC Q04756; Q92624: APPBP2; NbExp=3; IntAct=EBI-1041722, EBI-743771; CC Q04756; Q8TD31-3: CCHCR1; NbExp=3; IntAct=EBI-1041722, EBI-10175300; CC Q04756; Q8NBJ4: GOLM1; NbExp=3; IntAct=EBI-1041722, EBI-712073; CC Q04756; Q9BRI3: SLC30A2; NbExp=3; IntAct=EBI-1041722, EBI-8644112; CC Q04756; Q86XK7: VSIG1; NbExp=3; IntAct=EBI-1041722, EBI-18323486; CC -!- SUBCELLULAR LOCATION: Secreted. Note=Secreted as an inactive single- CC chain precursor and is then activated to a heterodimeric form. CC -!- TISSUE SPECIFICITY: Liver. CC -!- SIMILARITY: Belongs to the peptidase S1 family. {ECO:0000255|PROSITE- CC ProRule:PRU00274}. CC -!- CAUTION: It is uncertain whether Met-1 is the initiator. {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; D14012; BAA03113.1; -; mRNA. DR EMBL; BC112190; AAI12191.1; -; mRNA. DR EMBL; D50030; BAA74450.1; -; Genomic_DNA. DR EMBL; AL590235; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; CH471131; EAW82464.1; -; Genomic_DNA. DR EMBL; BC112192; AAI12193.1; -; mRNA. DR CCDS; CCDS3369.1; -. DR PIR; A46688; A46688. DR RefSeq; NP_001284368.1; NM_001297439.1. DR RefSeq; NP_001519.1; NM_001528.3. DR PDB; 1YBW; X-ray; 2.70 A; A/B=373-655. DR PDB; 1YC0; X-ray; 2.60 A; A=373-655. DR PDB; 2R0K; X-ray; 3.51 A; A=373-655. DR PDB; 2R0L; X-ray; 2.20 A; A=408-655, B=373-407. DR PDB; 2WUB; X-ray; 2.90 A; A/C=408-655, B/D=373-407. DR PDB; 2WUC; X-ray; 2.70 A; A=408-654, B=373-407. DR PDB; 3K2U; X-ray; 2.35 A; A=408-655, B=373-407. DR PDBsum; 1YBW; -. DR PDBsum; 1YC0; -. DR PDBsum; 2R0K; -. DR PDBsum; 2R0L; -. DR PDBsum; 2WUB; -. DR PDBsum; 2WUC; -. DR PDBsum; 3K2U; -. DR AlphaFoldDB; Q04756; -. DR SMR; Q04756; -. DR BioGRID; 109331; 25. DR DIP; DIP-6022N; -. DR IntAct; Q04756; 13. DR STRING; 9606.ENSP00000421801; -. DR BindingDB; Q04756; -. DR ChEMBL; CHEMBL3351190; -. DR DrugCentral; Q04756; -. DR MEROPS; S01.228; -. DR GlyConnect; 1309; 13 N-Linked glycans (4 sites). DR GlyCosmos; Q04756; 10 sites, 17 glycans. DR GlyGen; Q04756; 11 sites, 14 N-linked glycans (4 sites), 4 O-linked glycans (6 sites). DR iPTMnet; Q04756; -. DR PhosphoSitePlus; Q04756; -. DR BioMuta; HGFAC; -. DR DMDM; 547643; -. DR jPOST; Q04756; -. DR MassIVE; Q04756; -. DR MaxQB; Q04756; -. DR PaxDb; 9606-ENSP00000421801; -. DR PeptideAtlas; Q04756; -. DR ProteomicsDB; 58278; -. DR ABCD; Q04756; 3 sequenced antibodies. DR Antibodypedia; 3925; 199 antibodies from 23 providers. DR DNASU; 3083; -. DR Ensembl; ENST00000382774.8; ENSP00000372224.4; ENSG00000109758.9. DR GeneID; 3083; -. DR KEGG; hsa:3083; -. DR MANE-Select; ENST00000382774.8; ENSP00000372224.4; NM_001528.4; NP_001519.1. DR UCSC; uc003ghc.4; human. DR AGR; HGNC:4894; -. DR CTD; 3083; -. DR DisGeNET; 3083; -. DR GeneCards; HGFAC; -. DR HGNC; HGNC:4894; HGFAC. DR HPA; ENSG00000109758; Tissue enriched (liver). DR MIM; 604552; gene. DR neXtProt; NX_Q04756; -. DR OpenTargets; ENSG00000109758; -. DR PharmGKB; PA29270; -. DR VEuPathDB; HostDB:ENSG00000109758; -. DR eggNOG; KOG1217; Eukaryota. DR eggNOG; KOG3627; Eukaryota. DR GeneTree; ENSGT00940000159778; -. DR InParanoid; Q04756; -. DR OrthoDB; 4629979at2759; -. DR PhylomeDB; Q04756; -. DR TreeFam; TF329901; -. DR PathwayCommons; Q04756; -. DR Reactome; R-HSA-6806942; MET Receptor Activation. DR SignaLink; Q04756; -. DR BioGRID-ORCS; 3083; 3 hits in 1145 CRISPR screens. DR ChiTaRS; HGFAC; human. DR EvolutionaryTrace; Q04756; -. DR GeneWiki; HGFAC; -. DR GenomeRNAi; 3083; -. DR Pharos; Q04756; Tchem. DR PRO; PR:Q04756; -. DR Proteomes; UP000005640; Chromosome 4. DR RNAct; Q04756; Protein. DR Bgee; ENSG00000109758; Expressed in right lobe of liver and 89 other cell types or tissues. DR ExpressionAtlas; Q04756; baseline and differential. DR GO; GO:0005829; C:cytosol; TAS:Reactome. DR GO; GO:0005576; C:extracellular region; TAS:ProtInc. DR GO; GO:0005615; C:extracellular space; IBA:GO_Central. DR GO; GO:0005791; C:rough endoplasmic reticulum; IBA:GO_Central. DR GO; GO:0004252; F:serine-type endopeptidase activity; IBA:GO_Central. DR GO; GO:0008236; F:serine-type peptidase activity; TAS:ProtInc. DR GO; GO:0007596; P:blood coagulation; IBA:GO_Central. DR GO; GO:0006508; P:proteolysis; TAS:ProtInc. DR GO; GO:0031638; P:zymogen activation; IBA:GO_Central. DR CDD; cd00054; EGF_CA; 2. DR CDD; cd00061; FN1; 1. DR CDD; cd00062; FN2; 1. DR CDD; cd00108; KR; 1. DR CDD; cd00190; Tryp_SPc; 1. DR Gene3D; 2.10.10.10; Fibronectin, type II, collagen-binding; 1. DR Gene3D; 2.10.25.10; Laminin; 2. DR Gene3D; 2.40.20.10; Plasminogen Kringle 4; 1. DR Gene3D; 2.40.10.10; Trypsin-like serine proteases; 1. DR InterPro; IPR014394; Coagulation_fac_XII/HGFA. DR InterPro; IPR000742; EGF-like_dom. DR InterPro; IPR000083; Fibronectin_type1. DR InterPro; IPR000562; FN_type2_dom. DR InterPro; IPR036943; FN_type2_sf. DR InterPro; IPR000001; Kringle. DR InterPro; IPR013806; Kringle-like. DR InterPro; IPR018056; Kringle_CS. DR InterPro; IPR038178; Kringle_sf. DR InterPro; IPR009003; Peptidase_S1_PA. DR InterPro; IPR043504; Peptidase_S1_PA_chymotrypsin. DR InterPro; IPR001314; Peptidase_S1A. DR InterPro; IPR001254; Trypsin_dom. DR InterPro; IPR018114; TRYPSIN_HIS. DR InterPro; IPR033116; TRYPSIN_SER. DR PANTHER; PTHR24264:SF43; HEPATOCYTE GROWTH FACTOR ACTIVATOR; 1. DR PANTHER; PTHR24264; TRYPSIN-RELATED; 1. DR Pfam; PF00008; EGF; 2. DR Pfam; PF00040; fn2; 1. DR Pfam; PF00051; Kringle; 1. DR Pfam; PF00089; Trypsin; 1. DR PIRSF; PIRSF001146; Factor_XII_HGFA; 1. DR PRINTS; PR00722; CHYMOTRYPSIN. DR PRINTS; PR00013; FNTYPEII. DR PRINTS; PR00018; KRINGLE. DR SMART; SM00181; EGF; 2. DR SMART; SM00058; FN1; 1. DR SMART; SM00059; FN2; 1. DR SMART; SM00130; KR; 1. DR SMART; SM00020; Tryp_SPc; 1. DR SUPFAM; SSF57196; EGF/Laminin; 1. DR SUPFAM; SSF57440; Kringle-like; 2. DR SUPFAM; SSF50494; Trypsin-like serine proteases; 1. DR PROSITE; PS00022; EGF_1; 2. DR PROSITE; PS01186; EGF_2; 1. DR PROSITE; PS50026; EGF_3; 2. DR PROSITE; PS01253; FN1_1; 1. DR PROSITE; PS51091; FN1_2; 1. DR PROSITE; PS00023; FN2_1; 1. DR PROSITE; PS51092; FN2_2; 1. DR PROSITE; PS00021; KRINGLE_1; 1. DR PROSITE; PS50070; KRINGLE_2; 1. DR PROSITE; PS50240; TRYPSIN_DOM; 1. DR PROSITE; PS00134; TRYPSIN_HIS; 1. DR PROSITE; PS00135; TRYPSIN_SER; 1. DR Genevisible; Q04756; HS. PE 1: Evidence at protein level; KW 3D-structure; Direct protein sequencing; Disulfide bond; EGF-like domain; KW Glycoprotein; Hydrolase; Kringle; Protease; Reference proteome; Repeat; KW Secreted; Serine protease; Signal; Zymogen. FT SIGNAL 1..35 FT /evidence="ECO:0000269|PubMed:15340161" FT PROPEP 36..372 FT /note="Removed in mature form" FT /id="PRO_0000027911" FT CHAIN 373..407 FT /note="Hepatocyte growth factor activator short chain" FT /id="PRO_0000027912" FT CHAIN 408..655 FT /note="Hepatocyte growth factor activator long chain" FT /id="PRO_0000027913" FT DOMAIN 103..150 FT /note="Fibronectin type-II" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00478, FT ECO:0000255|PROSITE-ProRule:PRU00479" FT DOMAIN 160..198 FT /note="EGF-like 1" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00076" FT DOMAIN 200..240 FT /note="Fibronectin type-I" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00478" FT DOMAIN 241..279 FT /note="EGF-like 2" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00076" FT DOMAIN 286..367 FT /note="Kringle" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00121" FT DOMAIN 408..646 FT /note="Peptidase S1" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00274" FT REGION 64..102 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT ACT_SITE 447 FT /note="Charge relay system" FT /evidence="ECO:0000269|PubMed:15713485" FT ACT_SITE 497 FT /note="Charge relay system" FT /evidence="ECO:0000269|PubMed:15713485" FT ACT_SITE 598 FT /note="Charge relay system" FT /evidence="ECO:0000269|PubMed:15713485" FT CARBOHYD 48 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 290 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 468 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000269|PubMed:16335952, FT ECO:0000269|PubMed:18077410, ECO:0000269|PubMed:19159218" FT CARBOHYD 546 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT DISULFID 108..133 FT /evidence="ECO:0000250" FT DISULFID 122..148 FT /evidence="ECO:0000250" FT DISULFID 164..175 FT /evidence="ECO:0000250" FT DISULFID 169..186 FT /evidence="ECO:0000250" FT DISULFID 188..197 FT /evidence="ECO:0000250" FT DISULFID 202..230 FT /evidence="ECO:0000250" FT DISULFID 228..237 FT /evidence="ECO:0000250" FT DISULFID 245..256 FT /evidence="ECO:0000250" FT DISULFID 250..267 FT /evidence="ECO:0000250" FT DISULFID 269..278 FT /evidence="ECO:0000250" FT DISULFID 286..367 FT /evidence="ECO:0000250" FT DISULFID 307..349 FT /evidence="ECO:0000250" FT DISULFID 338..362 FT /evidence="ECO:0000250" FT DISULFID 394..521 FT /note="Interchain (between short and long chains)" FT DISULFID 432..448 FT DISULFID 440..510 FT DISULFID 535..604 FT DISULFID 567..583 FT DISULFID 594..622 FT VARIANT 218 FT /note="A -> S (in dbSNP:rs3748034)" FT /id="VAR_051851" FT VARIANT 225 FT /note="V -> M (in dbSNP:rs16844370)" FT /id="VAR_033651" FT VARIANT 231 FT /note="F -> L (in dbSNP:rs1987546)" FT /evidence="ECO:0000269|PubMed:15489334" FT /id="VAR_033652" FT VARIANT 509 FT /note="R -> H (in dbSNP:rs16844401)" FT /id="VAR_024294" FT VARIANT 644 FT /note="R -> Q (in dbSNP:rs2498323)" FT /id="VAR_024295" FT STRAND 422..427 FT /evidence="ECO:0007829|PDB:2R0L" FT STRAND 430..438 FT /evidence="ECO:0007829|PDB:2R0L" FT STRAND 441..444 FT /evidence="ECO:0007829|PDB:2R0L" FT HELIX 446..449 FT /evidence="ECO:0007829|PDB:2R0L" FT HELIX 455..457 FT /evidence="ECO:0007829|PDB:2R0L" FT STRAND 458..463 FT /evidence="ECO:0007829|PDB:2R0L" FT STRAND 475..477 FT /evidence="ECO:0007829|PDB:2R0L" FT STRAND 479..484 FT /evidence="ECO:0007829|PDB:2R0L" FT STRAND 490..492 FT /evidence="ECO:0007829|PDB:3K2U" FT TURN 493..496 FT /evidence="ECO:0007829|PDB:2R0L" FT STRAND 499..503 FT /evidence="ECO:0007829|PDB:2R0L" FT STRAND 506..508 FT /evidence="ECO:0007829|PDB:2R0L" FT STRAND 509..511 FT /evidence="ECO:0007829|PDB:1YC0" FT STRAND 514..516 FT /evidence="ECO:0007829|PDB:1YBW" FT STRAND 534..540 FT /evidence="ECO:0007829|PDB:2R0L" FT STRAND 543..546 FT /evidence="ECO:0007829|PDB:2R0L" FT STRAND 555..561 FT /evidence="ECO:0007829|PDB:2R0L" FT HELIX 564..567 FT /evidence="ECO:0007829|PDB:2R0L" FT TURN 570..573 FT /evidence="ECO:0007829|PDB:2R0L" FT HELIX 574..576 FT /evidence="ECO:0007829|PDB:2R0L" FT STRAND 581..585 FT /evidence="ECO:0007829|PDB:2R0L" FT STRAND 587..589 FT /evidence="ECO:0007829|PDB:2R0L" FT TURN 595..599 FT /evidence="ECO:0007829|PDB:1YBW" FT STRAND 601..606 FT /evidence="ECO:0007829|PDB:2R0L" FT STRAND 609..618 FT /evidence="ECO:0007829|PDB:2R0L" FT TURN 621..623 FT /evidence="ECO:0007829|PDB:2R0L" FT STRAND 625..627 FT /evidence="ECO:0007829|PDB:1YBW" FT STRAND 629..633 FT /evidence="ECO:0007829|PDB:2R0L" FT HELIX 634..637 FT /evidence="ECO:0007829|PDB:2R0L" FT HELIX 638..645 FT /evidence="ECO:0007829|PDB:2R0L" SQ SEQUENCE 655 AA; 70682 MW; 2CF72F1E1B862ED7 CRC64; MGRWAWVPSP WPPPGLGPFL LLLLLLLLLP RGFQPQPGGN RTESPEPNAT ATPAIPTILV TSVTSETPAT SAPEAEGPQS GGLPPPPRAV PSSSSPQAQA LTEDGRPCRF PFRYGGRMLH ACTSEGSAHR KWCATTHNYD RDRAWGYCVE ATPPPGGPAA LDPCASGPCL NGGSCSNTQD PQSYHCSCPR AFTGKDCGTE KCFDETRYEY LEGGDRWARV RQGHVEQCEC FGGRTWCEGT RHTACLSSPC LNGGTCHLIV ATGTTVCACP PGFAGRLCNI EPDERCFLGN GTGYRGVAST SASGLSCLAW NSDLLYQELH VDSVGAAALL GLGPHAYCRN PDNDERPWCY VVKDSALSWE YCRLEACESL TRVQLSPDLL ATLPEPASPG RQACGRRHKK RTFLRPRIIG GSSSLPGSHP WLAAIYIGDS FCAGSLVHTC WVVSAAHCFS HSPPRDSVSV VLGQHFFNRT TDVTQTFGIE KYIPYTLYSV FNPSDHDLVL IRLKKKGDRC ATRSQFVQPI CLPEPGSTFP AGHKCQIAGW GHLDENVSGY SSSLREALVP LVADHKCSSP EVYGADISPN MLCAGYFDCK SDACQGDSGG PLACEKNGVA YLYGIISWGD GCGRLHKPGV YTRVANYVDW INDRIRPPRR LVAPS //